# Hans Herfarth

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hans-herfarth/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,532 |
| Field | Inflammatory Bowel Disease |
| h-index | 73 |
| i10-index | 205 |
| Last Known Institution | University of North Carolina at Chapel Hill |
| OpenAlex ID | https://openalex.org/A5079998509 |
| ORCID iD | https://orcid.org/0000-0003-4268-823X |
| Works | 546 |

## Researcher papers

- [Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial](https://scholariq.org/papers/ustekinumab-versus-adalimumab-for-induction-and-maintenance-therapy-in-biologic/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Diverticular Disease and Complications](https://scholariq.org/topics/diverticular-disease-and-complications/)

## Researcher university

- [University of North Carolina at Chapel Hill](https://scholariq.org/institutions/university-of-north-carolina-at-chapel-hill/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.